Skip to content

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

Interleukin-2 shows no benefit in two large clinical trials

Seminal HIV: cell-free virus, not infected cells, leads to transmission between men

Microbicide reduces HIV infections by 30% in first success for field

Test can predict non-Hodgkin's lymphoma in people with HIV

When to start HIV treatment: cohort studies disagree on how early

HIV sporadically detectable in semen of men with undetectable plasma viral loads

High-dose tenofovir microbicide completely protects monkeys